• Markets
    • icon
  • Companies
1AI · ASX

Algorae Pharmaceuticals Limited (ASX:1AI)

AU$0.013

 0.0 (0.0%)
ASX:Live
01/12/2023 09:59:47 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

1AI Overview

1AI Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About 1AI

Website

Algorae Pharmaceuticals Limited

Telephone

64.9.276.2690

Address

Unit 107 23 Edwin Street Mount Eden, Auckland 1024

Description

Algorae Pharmaceuticals Ltd. is a biotechnology company, which engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Mount Eden, New Zealand.

1AI Price Chart

Key Stats

Market Cap

AU$21.60M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.02

Trade Value (12mth)

AU$3,272.00

1 week

8.33%

1 month

0%

YTD

9.69%

1 year

-22.57%

All time high

0.58513

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

-$2m

Free Cash Flow Return

-51.00%

ROIC

-54.10%

Interest Coverage

N/A

Quick Ratio

9.40

Other Data

Shares on Issue (Fully Dilluted)

1461m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

1AI Announcements

Latest Announcements

Date Announcements

31 October 23

CSIRO Grant for Artificial Intelligence Platform

×

CSIRO Grant for Artificial Intelligence Platform

28 September 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

27 October 23

Quarterly Activities/Appendix 5B Cash Flow Report

×

Quarterly Activities/Appendix 5B Cash Flow Report

25 October 23

1AI develops Artificial Intelligence Platform

×

1AI develops Artificial Intelligence Platform

24 October 23

Corporate Governance Statement

×

Corporate Governance Statement

23 November 23

1AI commences AI-168 pre-clinical studies

×

1AI commences AI-168 pre-clinical studies

21 November 23

Addendum to September Quarterly Report

×

Addendum to September Quarterly Report

17 October 23

Cleansing Statement

×

Cleansing Statement

16 October 23

Proposed issue of securities - 1AI

×

Proposed issue of securities - 1AI

16 October 23

Change of Director's Interest Notice x2

×

Change of Director's Interest Notice x2

12 September 23

2023 Annual General Meeting Date

×

2023 Annual General Meeting Date

12 September 23

Appendix 4G

×

Appendix 4G

11 September 23

MOU with UNSW to develop AI Platform

×

MOU with UNSW to develop AI Platform

10 November 23

Appendix 3y and Amended Cleansing Statement

×

Appendix 3y and Amended Cleansing Statement

10 November 23

Application for quotation of securities - 1AI

×

Application for quotation of securities - 1AI

10 November 23

Appendix 3Y x 3 and Cleansing Statement

×

Appendix 3Y x 3 and Cleansing Statement

08 November 23

Application for quotation of securities - 1AI

×

Application for quotation of securities - 1AI

08 November 23

Proposed issue of securities - 1AI

×

Proposed issue of securities - 1AI

08 November 23

Notification regarding unquoted securities - 1AI

×

Notification regarding unquoted securities - 1AI

08 November 23

Cleansing Statement

×

Cleansing Statement

07 November 23

Proposed issue of securities - 1AI

×

Proposed issue of securities - 1AI

02 November 23

AGM Chairman Address to Shareholders

×

AGM Chairman Address to Shareholders

02 November 23

Results of Meeting

×

Results of Meeting

1AI Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A N/A -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A N/A -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A N/A -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A N/A -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A -9.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A N/A 1,347 Lock Lock Lock
Basic m Lock Lock Lock Lock N/A N/A 1,347 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A N/A 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A N/A -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A N/A -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A N/A -2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A N/A -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A N/A -2 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A N/A 2 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A N/A -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A N/A 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A N/A 4 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A N/A -4 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A N/A 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A N/A 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A N/A -50.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A -56.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A N/A -54.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A N/A -54.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A N/A -51.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A N/A 1.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A N/A -109.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A N/A 9.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A N/A 9.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A N/A 97.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A N/A -441.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A N/A -50.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A N/A 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A -56.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A N/A 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A N/A -56.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 76,041.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A -76,041.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

1AI Shortsell

Frequently Asked Questions

The current share price of Algorae Pharmaceuticals Limited (1AI:ASX) is AU$0.013.
The 52-week high share price for Algorae Pharmaceuticals Limited (1AI:ASX) is AU$0.02.
The 52-week low share price for Algorae Pharmaceuticals Limited (1AI:ASX)? is AU$0.01.
Algorae Pharmaceuticals Limited (1AI:ASX) does not pay a dividend.
Algorae Pharmaceuticals Limited (1AI:ASX) does not pay a dividend.
Algorae Pharmaceuticals Limited (1AI:ASX) has a franking level of 0%.
Algorae Pharmaceuticals Limited (1AI:ASX) is classified in the Healthcare.
The current P/E ratio for Algorae Pharmaceuticals Limited (1AI:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.